These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 23415089)

  • 41. Entropy model for multiplex drug-target interaction endpoints of drug immunotoxicity.
    Tenorio-Borroto E; García-Mera X; Peñuelas-Rivas CG; Vásquez-Chagoyán JC; Prado-Prado FJ; Castañedo N; González-Díaz H
    Curr Top Med Chem; 2013; 13(14):1636-49. PubMed ID: 23889053
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multitasking models for quantitative structure-biological effect relationships: current status and future perspectives to speed up drug discovery.
    Speck-Planche A; Cordeiro MN
    Expert Opin Drug Discov; 2015 Mar; 10(3):245-56. PubMed ID: 25613725
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's disease.
    Chen JJ; Swope DM; Dashtipour K
    Clin Ther; 2007 Sep; 29(9):1825-49. PubMed ID: 18035186
    [TBL] [Abstract][Full Text] [Related]  

  • 45. PTML Model for Selection of Nanoparticles, Anticancer Drugs, and Vitamins in the Design of Drug-Vitamin Nanoparticle Release Systems for Cancer Cotherapy.
    Santana R; Zuluaga R; Gañán P; Arrasate S; Onieva E; Montemore MM; González-Díaz H
    Mol Pharm; 2020 Jul; 17(7):2612-2627. PubMed ID: 32459098
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Perturbation Theory/Machine Learning Model of ChEMBL Data for Dopamine Targets: Docking, Synthesis, and Assay of New l-Prolyl-l-leucyl-glycinamide Peptidomimetics.
    Ferreira da Costa J; Silva D; Caamaño O; Brea JM; Loza MI; Munteanu CR; Pazos A; García-Mera X; González-Díaz H
    ACS Chem Neurosci; 2018 Nov; 9(11):2572-2587. PubMed ID: 29791132
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fingerprint-based clustering applied to define a QSAR model use radius.
    Sprous DG
    J Mol Graph Model; 2008 Sep; 27(2):225-32. PubMed ID: 18556228
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Unified QSAR & network-based computational chemistry approach to antimicrobials. II. Multiple distance and triadic census analysis of antiparasitic drugs complex networks.
    Prado-Prado FJ; Ubeira FM; Borges F; González-Díaz H
    J Comput Chem; 2010 Jan; 31(1):164-73. PubMed ID: 19421992
    [TBL] [Abstract][Full Text] [Related]  

  • 49. TOPS-MODE based QSARs derived from heterogeneous series of compounds. Applications to the design of new anti-inflammatory compounds.
    Pérez González M; Dias LC; Helguera AM; Rodríguez YM; de Oliveira LG; Gomez LT; Diaz HG
    Bioorg Med Chem; 2004 Aug; 12(16):4467-75. PubMed ID: 15265497
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular docking and 3D-QSAR studies of 2-substituted 1-indanone derivatives as acetylcholinesterase inhibitors.
    Shen LL; Liu GX; Tang Y
    Acta Pharmacol Sin; 2007 Dec; 28(12):2053-63. PubMed ID: 18031622
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rasagiline: a novel anti-Parkinsonian monoamine oxidase-B inhibitor with neuroprotective activity.
    Weinreb O; Amit T; Bar-Am O; Youdim MB
    Prog Neurobiol; 2010 Nov; 92(3):330-44. PubMed ID: 20600573
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Using the TOPS-MODE approach to fit multi-target QSAR models for tyrosine kinases inhibitors.
    Marzaro G; Chilin A; Guiotto A; Uriarte E; Brun P; Castagliuolo I; Tonus F; González-Díaz H
    Eur J Med Chem; 2011 Jun; 46(6):2185-92. PubMed ID: 21447431
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multi-target spectral moment: QSAR for antifungal drugs vs. different fungi species.
    Prado-Prado FJ; Borges F; Perez-Montoto LG; González-Díaz H
    Eur J Med Chem; 2009 Oct; 44(10):4051-6. PubMed ID: 19467743
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dragon method for finding novel tyrosinase inhibitors: Biosilico identification and experimental in vitro assays.
    Casañola-Martín GM; Marrero-Ponce Y; Khan MT; Ather A; Khan KM; Torrens F; Rotondo R
    Eur J Med Chem; 2007; 42(11-12):1370-81. PubMed ID: 17637486
    [TBL] [Abstract][Full Text] [Related]  

  • 55. QSAR-based solubility model for drug-like compounds.
    Gozalbes R; Pineda-Lucena A
    Bioorg Med Chem; 2010 Oct; 18(19):7078-84. PubMed ID: 20810286
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rasagiline (TVP-1012): a new selective monoamine oxidase inhibitor for Parkinson's disease.
    Guay DR
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):330-46. PubMed ID: 17296539
    [TBL] [Abstract][Full Text] [Related]  

  • 57. QSAR classification model for antibacterial compounds and its use in virtual screening.
    Singh N; Chaudhury S; Liu R; AbdulHameed MD; Tawa G; Wallqvist A
    J Chem Inf Model; 2012 Oct; 52(10):2559-69. PubMed ID: 23013546
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Application of
    Haider M; Chauhan A; Tariq S; Pathak DP; Siddiqui N; Ali S; Pottoo FH; Ali R
    Curr Top Med Chem; 2021; 21(11):995-1011. PubMed ID: 34061002
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Is good old minocycline a new neuroprotective drug?].
    Melero-Fernández de Mera RM; García-Martínez E; Fernández-Gómez FJ; Hernández-Guijo JM; Aguirre N; Galindo MF; Jordán J
    Rev Neurol; 2008 Jul 1-15; 47(1):31-8. PubMed ID: 18592478
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Critically Assessing the Predictive Power of QSAR Models for Human Liver Microsomal Stability.
    Liu R; Schyman P; Wallqvist A
    J Chem Inf Model; 2015 Aug; 55(8):1566-75. PubMed ID: 26170251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.